Cormorant Asset Management, LP Atara Biotherapeutics, Inc. Transaction History

Cormorant Asset Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$10.89 - $16.79 $3.27 Million - $5.04 Million	-300,000 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$12.03 - $19.94 $1.2 Million - $1.99 Million	-100,000 Reduced 25.0%	300,000 $4.24 Million
Q2 2019 Aug 14, 2019	SELL	$19.05 - $41.04 $2.86 Million - $6.16 Million	-150,000 Reduced 27.27%	400,000 $8.04 Million
Q1 2019 May 15, 2019	BUY	$28.4 - $41.74 $15.6 Million - $23 Million	550,000 New	550,000 $21.9 Million

2.89M

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.08B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Cormorant Asset Management, LP with notifications on news.